Transforming the rare disease landscape: The essential role of patient advocacy groups and pharma
Discover how patient advocacy groups (PAGs) are transforming rare disease research by bridging the gap between patients, caregivers, and the pharmaceutical industry. Learn more about their mission to improve healthcare outcomes and how the pharmaceutical industry can collaborate to develop life-changing therapies for those most in need.